Lane v. Cancer Treatment Centers of America, Inc.

BVLaw
Full Text of Court Cases
July 30, 2004

Access the Full Article

This article and its downloads are available with a subscription to any of these products:
It is also available in this product:
Already a subscriber or product owner?  Login
This article is also available for purchase. (29,152 words)   Add to Cart >>
Need help? Contact us:
1-503-479-8200 ext 2 or sales@bvresources.com
shareholder dissent/oppression
Lane v. Cancer Treatment Centers of America, Inc.
No. 12207 (Del. Chan. 2004)
US
State Court
Delaware
Court of Chancery
Thomas P. White
Richard S. Baehr <br> Robert J. Cimasi, ASA <br>
Noble

Summary

The Delaware Court of Chancery determined the fair value of a closely held, subchapter S corporation’s stock. The primary reason for the great differences in value determined by the opposing experts in this case resulted from the assumptions regarding the ...
Lane v. Cancer Treatment Centers of America, Inc.
PDF, Size: 321 KB

See Also

Delaware Critiques Conventional BV Models for Valuing an Emerging, Short-Lived Niche Company But Goes With DCF

Legal and Court Case Update
November 2004

The issue in this appraisal action, filed by Robert Michael Lane, was the fair value of the common stock of Cancer Treatment Centers of America Inc. (CTCA or the Company).

This article also appears in:
Valuation Cases From the Delaware Court of Chancery Show How to Excel